The spatial immune ecosystem of multiple myeloma: cellular neighborhoods, disease evolution, and emerging therapeutic implications

Multiple myeloma (MM) develops in the bone marrow but is distributed across a heterogeneous skeletal system. This creates an inherent sampling problem: most molecular and immune studies rely on a single marrow aspirate to represent disease that may differ substantially across anatomical sites. Single-cell approaches have greatly expanded our understanding of malignant and non-malignant cell states, but tissue dissociation removes the spatial information needed to determine whether immune cells infiltrate, surround, or avoid plasma-cell-rich regions. In this Review, we consider MM as a nested spatial immune ecosystem extending from lesion distribution across the skeleton to regional tissue architecture and local cellular neighborhoods. We distinguish direct in situ evidence from macrospatial, dissociative single-cell, and mechanistic support, and examine emerging configurations including plasma-cell-dominated territories, T-cell-rich immune islands, inflammatory stromal associations, bone- and vascular-linked compartments, and immune-metabolic neighborhoods. These studies also suggest that immune competence cannot be inferred from cell abundance alone; access to tumor-rich regions, cellular state, and local function are equally relevant. Current studies describe spatial differences across disease states and regional changes that accompany acquired daratumumab resistance. Most of this work, however, is observational and does not establish causal effects of neighborhood organization on disease progression or treatment response. Moving beyond descriptive maps will require reproducible spatial measurements, functional validation, and prospective testing in treatment-defined cohorts. We therefore propose a five-step translational framework—map, validate, perturb, predict, and intervene—to convert spatial observations into testable mechanisms, clinically informative biomarkers, and spatially informed therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-18
DOI
https://doi.org/10.3389/fimmu.2026.1981020
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The spatial immune ecosystem of multiple myeloma: cellular neighborhoods, disease evolution, and emerging therapeutic implications

Xiuqin Zuo, Liu Tang, Xiaofeng Zhu
7 links
Frontiers in Immunology
Multiple Myeloma Research and Treatments
article

The spatial immune ecosystem of multiple myeloma: cellular neighborhoods, disease evolution, and emerging therapeutic implications

Xiuqin Zuo, Liu Tang, Xiaofeng Zhu
article en

Abstract

Multiple myeloma (MM) develops in the bone marrow but is distributed across a heterogeneous skeletal system. This creates an inherent sampling problem: most molecular and immune studies rely on a single marrow aspirate to represent disease that may differ substantially across anatomical sites. Single-cell approaches have greatly expanded our understanding of malignant and non-malignant cell states, but tissue dissociation removes the spatial information needed to determine whether immune cells infiltrate, surround, or avoid plasma-cell-rich regions. In this Review, we consider MM as a nested spatial immune ecosystem extending from lesion distribution across the skeleton to regional tissue architecture and local cellular neighborhoods. We distinguish direct in situ evidence from macrospatial, dissociative single-cell, and mechanistic support, and examine emerging configurations including plasma-cell-dominated territories, T-cell-rich immune islands, inflammatory stromal associations, bone- and vascular-linked compartments, and immune-metabolic neighborhoods. These studies also suggest that immune competence cannot be inferred from cell abundance alone; access to tumor-rich regions, cellular state, and local function are equally relevant. Current studies describe spatial differences across disease states and regional changes that accompany acquired daratumumab resistance. Most of this work, however, is observational and does not establish causal effects of neighborhood organization on disease progression or treatment response. Moving beyond descriptive maps will require reproducible spatial measurements, functional validation, and prospective testing in treatment-defined cohorts. We therefore propose a five-step translational framework—map, validate, perturb, predict, and intervene—to convert spatial observations into testable mechanisms, clinically informative biomarkers, and spatially informed therapeutic strategies.

Frontiers in ImmunologyVol. 17
Southwest Medical University (CN), Affiliated Hospital of Southwest Medical University (CN)
Good health and well-being
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon